Cytokinetics Inc (NASDAQ:CYTK)

Delayed Data
As of Mar 22
 -0.15 / -1.76%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 15.00, with a high estimate of 20.00 and a low estimate of 10.00. The median estimate represents a +79.64% increase from the last price of 8.35.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 40.89%
Growthannually 23.17%


Growthquarterly 50,655.56%
Growthannually 44.60%
Key to the earnings and sales forecast charts.